全文获取类型
收费全文 | 194篇 |
免费 | 62篇 |
专业分类
儿科学 | 39篇 |
妇产科学 | 1篇 |
基础医学 | 93篇 |
口腔科学 | 2篇 |
临床医学 | 10篇 |
内科学 | 20篇 |
皮肤病学 | 8篇 |
神经病学 | 24篇 |
特种医学 | 2篇 |
外科学 | 5篇 |
预防医学 | 6篇 |
药学 | 5篇 |
肿瘤学 | 41篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 9篇 |
2020年 | 12篇 |
2019年 | 8篇 |
2018年 | 21篇 |
2017年 | 19篇 |
2016年 | 14篇 |
2015年 | 12篇 |
2014年 | 19篇 |
2013年 | 7篇 |
2012年 | 12篇 |
2011年 | 11篇 |
2010年 | 7篇 |
2009年 | 4篇 |
2008年 | 10篇 |
2007年 | 6篇 |
2006年 | 8篇 |
2005年 | 8篇 |
2004年 | 10篇 |
2003年 | 7篇 |
2002年 | 6篇 |
2001年 | 6篇 |
2000年 | 3篇 |
1999年 | 7篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1993年 | 1篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 2篇 |
排序方式: 共有256条查询结果,搜索用时 15 毫秒
1.
2.
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. 总被引:3,自引:0,他引:3
S Mariani M Muraro F Pantaleoni F Fiore B Nuschak S Peola M Foglietta A Palumbo M Coscia B Castella B Bruno R Bertieri L Boano M Boccadoro M Massaia 《Leukemia》2005,19(4):664-670
The aim of this study was to investigate the in vitro immunomodulatory effects of zoledronic acid (Zol) on peripheral blood Vgamma9/Vdelta2 (gammadelta) T cells of normal donors and multiple myeloma (MM) patients. gammadelta T cells were stimulated with Zol and low doses of interleukin-2 (IL-2), and then analyzed for proliferation, cytokine production, and generation of effector activity against myeloma cell lines and primary myeloma cells. Proliferation of gammadelta T cells was observed in 100% of normal donors and 50% of MM patients. gammadelta T cells produced IFN-gamma, surface mobilized the CD107a and CD107b antigens, and exerted direct cell-to-cell antimyeloma activity irrespective of the ability to proliferate to Zol and IL-2. The memory phenotype was predominant in the MM gammadelta T cells that proliferated in response to Zol (responders), whereas effector cells were predominant in those that did not (nonresponders). Zol induced antimyeloma activity through the monocyte-dependent activation of gammadelta T cells and by enhancing the immunosensitivity of myeloma cells to gammadelta T cells. Mevastatin, a specific inhibitor of hydroxy-methylglutaryl-CoA reductase, completely abrogated this antimyeloma activity. 相似文献
3.
Alberto E. Tozzi Lucio Armenio Roberto Bernardini Attilio Boner Mauro Calvani Fabio Cardinale Giovanni Cavagni Arianna Dondi Marzia Duse Alessandro Fiocchi Gian L. Marseglia Michele Miraglia del Giudice Antonella Muraro Giovanni B. Pajno Francesco Paravati Diego Peroni Salvatore Tripodi Alberto G. Ugazio Luciana Indinnimeo 《Pediatric allergy and immunology》2011,22(3):267-276
4.
Nuclear fractal dimension in oral squamous cell carcinoma: a novel method for the evaluation of grading,staging, and survival 下载免费PDF全文
Gabriella Mincione Marta Di Nicola Maria Carmela Di Marcantonio Raffaella Muraro Adriano Piattelli Corrado Rubini Enrico Penitente Marcello Piccirilli Giuseppe Aprile Vittoria Perrotti Luciano Artese 《Journal of oral pathology & medicine》2015,44(9):680-684
Fractal dimension (FD) in tissue specimens from patients with oral squamous cell carcinoma (OSCC) was evaluated. FD values in different stages of OSCC, and the correlations with clinicopathological variables and patient survival were investigated. Histological sections from OSCC and control non‐neoplastic mucosa specimens were stained with hematoxylin–eosin for pathological analysis and with Feulgen for nuclear evaluation. FD in OSCC groups vs. controls revealed statistically significant differences (P < 0.001). In addition, a progressive increase of FD from stage I and II lesions and stage III and IV lesions was observed, with statistically significant differences (P = 0.003). Moreover, different degrees of tumor differentiation showed a significant difference in the average nuclear FD values (P = 0.001). A relationship between FD and patients' survival was also detected with lower FD values associated to longer survival time and higher FD values with shorter survival time (P = 0.034). These data showed that FD significantly increased during OSCC progression. Thus, FD could represent a novel prognostic tool for OSCC, as FD values significantly correlated with patient survival. Fractal geometry could give insights into tumor morphology and could become an useful tool for analyzing irregular tumor growth patterns. 相似文献
5.
Antonio Nieto Ulrich Wahn Albrecht Bufe Philippe Eigenmann Susanne Halken Gunilla Hedlin Arne Høst Jonathan Hourihane Jocelyne Just Gideon Lack Susanne Lau Paolo Maria Matricardi Antonella Muraro Nikos Papadopoulos Graham Roberts Angela Simpson Erkka Valovirta Stephan Weidinger Magnus Wickman Angel Mazon 《Pediatric allergy and immunology》2014,25(6):516-533
6.
Susanne Halken Desiree Larenas‐Linnemann Graham Roberts Moises A. Calderón Elisabeth Angier Oliver Pfaar Dermot Ryan Ioana Agache Ignacio J. Ansotegui Stefania Arasi George Du Toit Montserrat Fernandez‐Rivas Roy Geerth van Wijk Marek Jutel Jörg Kleine‐Tebbe Susanne Lau Paolo M. Matricardi Giovanni B. Pajno Nikolaos G. Papadopoulos Martin Penagos Alexandra F. Santos Gunter J. Sturm Frans Timmermans R. van Ree Eva‐Maria Varga Ulrich Wahn Maria Kristiansen Sangeeta Dhami Aziz Sheikh Antonella Muraro 《Pediatric allergy and immunology》2017,28(8):728-745
Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond cessation of AIT that may include important preventive effects. The European Academy of Allergy and Clinical Immunology (EAACI) has developed a clinical practice guideline to provide evidence‐based recommendations for AIT for the prevention of (i) development of allergic comorbidities in those with established allergic diseases, (ii) development of first allergic condition, and (iii) allergic sensitization. This guideline has been developed using the Appraisal of Guidelines for Research & Evaluation (AGREE II) framework, which involved a multidisciplinary expert working group, a systematic review of the underpinning evidence, and external peer‐review of draft recommendations. Our key recommendation is that a 3‐year course of subcutaneous or sublingual AIT can be recommended for children and adolescents with moderate‐to‐severe allergic rhinitis (AR) triggered by grass/birch pollen allergy to prevent asthma for up to 2 years post‐AIT in addition to its sustained effect on AR symptoms and medication. Some trial data even suggest a preventive effect on asthma symptoms and medication more than 2 years post‐AIT. We need more evidence concerning AIT for prevention in individuals with AR triggered by house dust mites or other allergens and for the prevention of allergic sensitization, the first allergic disease, or for the prevention of allergic comorbidities in those with other allergic conditions. Evidence for the preventive potential of AIT as disease‐modifying treatment exists but there is an urgent need for more high‐quality clinical trials. 相似文献
7.
Doreen Siegels Annice Heratizadeh Susanne Abraham Jonas Binnmyr Knut Brockow Alan D. Irvine Susanne Halken Charlotte G Mortz Carsten Flohr Peter Schmid-Grendelmeier Lauri-Ann Van der Poel Antonella Muraro Stephan Weidinger Thomas Werfel Jochen Schmitt the European Academy of Allergy Clinical Immunology Atopic Dermatitis Guideline group 《Allergy》2021,76(4):1053-1076
8.
Carina Venter Matthew Greenhawt Rosan W. Meyer Carlo Agostoni Imke Reese George du Toit Mary Feeney Kate Maslin Bright I. Nwaru Caroline Roduit Eva Untersmayr Berber Vlieg-Boerstra Isabella Pali-Schöll Graham C. Roberts Peter Smith Cezmi A. Akdis Ioana Agache Miriam Ben-Adallah Stephan Bischoff Remo Frei Holger Garn Kate Grimshaw Karin Hoffmann-Sommergruber Nonhlanhla Lunjani Antonella Muraro Lars K. Poulsen Harald Renz Milena Sokolowska Catherine Stanton Liam O'Mahony 《Allergy》2020,75(3):497-523
To fully understand the role of diet diversity on allergy outcomes and to set standards for conducting research in this field, the European Academy of Allergy and Clinical Immunology Task Force on Diet and Immunomodulation has systematically explored the association between diet diversity and allergy outcomes. In addition, a detailed narrative review of information on diet quality and diet patterns as they pertain to allergic outcomes is presented. Overall, we recommend that infants of any risk category for allergic disease should have a diverse diet, given no evidence of harm and some potential association of benefit in the prevention of particular allergic outcomes. In order to harmonize methods for future data collection and reporting, the task force members propose relevant definitions and important factors for consideration, when measuring diet diversity in the context of allergy. Consensus was achieved on practice points through the Delphi method. It is hoped that the definitions and considerations described herein will also enable better comparison of future studies and improve mechanistic studies and pathway analysis to understand how diet diversity modulates allergic outcomes. 相似文献
9.
M. Jutel N. G. Papadopoulos H. Gronlund H.‐J. Hoffman B. Bohle P. Hellings G.‐J. Braunsthal A. Muraro P. Schmid‐Grendelmeier T. Zuberbier I. Agache 《Allergy》2014,69(6):708-718
The majority of patients seeking medical advice for allergic diseases are first seen in a primary care setting. Correct diagnosis with identification of all offending allergens is an absolute prerequisite for appropriate management of allergic disease by the general practitioner. Allergy diagnostic tests recommended for use in primary care are critically reviewed in accordance with the significant workload in a primary care setting. Simplified pathways for recognition and diagnosis of allergic diseases are proposed, that should be further adapted to local (national) conditions. 相似文献